IP Library › Granted Patent US 10,155,018
Granted Patent B1
US 10,155,018 · App. 15/642,685 · Granted Dec 18, 2018

Method of improving sexual response and sensitivity

Inventor: Dennis M. Jenn (South Jordan, UT)
Assignee: ILYSM, LLC
A61K36/185A21D13/40A23C15/12A23L27/2052A61K9/007A61K9/0034A61K31/05A61K31/352A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,155,018
App. No.
15/642,685
Granted
Dec 18, 2018
Kind
B1
Abstract

Pharmaceutical preparations include at least one component that enhances sexual response and at least one other compound that enhances sexual sensitivity and pleasure. The component that enhances sexual response enhances blood flow to the genital region. Examples include compounds that dilate blood vessels, such as compounds that increase the amount of nitric oxide (NO) in the blood. The component that enhances sexual sensitivity and pleasure includes one or more cannabinoid compounds from the plant genus Cannabis . Examples include tetrahydrocannabinol (THC), the main psychoactive constituent of Cannabis , and cannabidiol (CBD), which is less or non-psychoactive and modulates THC activity. The ratio of THC/CBD can be selected depending on age, gender, physical health, and/or psychological condition of the user.

Claims (26)

1. A method of treating erectile dysfunction in a human in need thereof consisting essentially of:

a) orally administering by ingestion which is not smoking to said human in need thereof a therapeutically effective amount of a cannabis extract consisting essentially of at least one of tetrahydrocannabinol and cannabidiol; and

b) orally administering by ingestion which is not smoking to said human in need thereof a therapeutically effective amount of a sexual response component selected from the group consisting of sildenafil, tadalafil, and vardenafil which effectively treats said erectile dysfunction in said human in need thereof.

2. The method of claim 1 , wherein the cannabis extract contains about 10-500 mg of tetrahydrocannabinol.

3. The method of claim 1 , wherein the cannabis extract contains about 10-250 mg of tetrahydrocannabinol.

4. The method of claim 1 , wherein the cannabis extract contains about 10-500 mg of cannabidiol.

5. The method of claim 1 , wherein the cannabis extract contains about 10-250 mg of cannabidiol.

6. The method of claim 1 , wherein the cannabis extract consists essentially of tetrahydrocannabinol, and/or cannabidiol, and one of cannabinol, tetrahydrocannabivarin, cannabigerol, dronabinol, or nabilone.

7. The method of claim 1 , wherein the cannabis extract is administered as an infused edible.

8. The method of claim 1 , wherein the cannabis extract is administered as an oral drop.

9. The method of claim 1 , wherein said sexual response component is sildenafil.

10. The method of claim 1 , wherein the cannabis extract is administered as a capsule or tablet.

11. The method of claim 1 , wherein said sexual response component is tadalafil.

12. The method of claim 1 , wherein the sexual response component is administered as a capsule or tablet.

13. The method of claim 1 , wherein the sexual response component is vardenafil.

14. The method of claim 1 , further consisting essentially of orally administering by ingestion which is not smoking to said human a supplement selected from the group consisting of L-arginine, ginseng , gingko biloba , yohimbe, horny goat weed, and combinations thereof.

15. A method of treating erectile dysfunction in a human in need thereof consisting essentially of:

a) orally administering by ingestion which is not smoking to said human in need thereof a therapeutically effective amount of a cannabis extract consisting essentially of tetrahydrocannabinol and cannabidiol; and

b) orally administering by ingestion which is not smoking to said human in need thereof a therapeutically effective amount of a sexual response component selected from the group consisting of sildenafil, tadalafil, and vardenafil which effectively treats said erectile dysfunction in said human in need thereof.

16. The method of claim 15 , further consisting essentially of orally administering by ingestion which is not smoking to said human a supplement selected from the group consisting of L-arginine, ginseng , gingko biloba , yohimbe, horny goat weed, and combinations thereof.

17. A method of treating erectile dysfunction in a human in need thereof consisting essentially of:

a) orally administering by ingestion which is not smoking to said human in need thereof a therapeutically effective amount of a cannabis extract consisting essentially of about 10-500 mg of at least one of tetrahydrocannabinol and cannabidiol; and

b) orally administering by ingestion which is not smoking to said human in need thereof a therapeutically effective amount of a sexual response component selected from the group consisting of sildenafil, tadalafil, and vardenafil which effectively treats said erectile dysfunction in said human in need thereof.

18. The method of claim 17 , wherein said sexual response component is sildenafil or vardenafil.

19. The method of claim 17 , further consisting essentially of orally administering by ingestion which is not smoking to said human a supplement selected from the group consisting of L-arginine, ginseng , gingko biloba , yohimbe, horny goat weed, and combinations thereof.

20. The method of claim 17 , wherein the cannabis extract consists essentially of tetrahydrocannabinol, and/or cannabidiol, and one of cannabinol, tetrahydrocannabivarin, cannabigerol, dronabinol, or nabilone.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2021
From: ILYSM, LLC
To: ILYLT, LLC
Reel/Frame 055062/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2018
From: JENN, DENNIS M
To: ILYSM, LLC
Reel/Frame 046556/0915 →
Continuity (2)
Division 14538527 · Nov 11, 2014
Provisional Application 61902501 · Nov 11, 2013
Cited By (4)
US 12,186,280 US 12,268,699 US 12,409,131 US 12,409,132